Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
-
Published:2023-06-27
Issue:4
Volume:18
Page:559-570
-
ISSN:1776-2596
-
Container-title:Targeted Oncology
-
language:en
-
Short-container-title:Targ Oncol
Author:
Santoni MatteoORCID, Massari Francesco, Myint Zin W., Iacovelli Roberto, Pichler Martin, Basso Umberto, Kopecky Jindrich, Kucharz Jakub, Buti Sebastiano, Rizzo Mimma, Galli Luca, Büttner Thomas, De Giorgi Ugo, Kanesvaran Ravindran, Fiala Ondřej, Grande Enrique, Zucali Paolo Andrea, Fornarini Giuseppe, Bourlon Maria T., Scagliarini Sarah, Molina-Cerrillo Javier, Aurilio Gaetano, Matrana Marc R., Pichler Renate, Cattrini Carlo, Büchler Tomas, Seront Emmanuel, Calabrò Fabio, Pinto Alvaro, Berardi Rossana, Zgura Anca, Mammone Giulia, Ansari Jawaher, Atzori Francesco, Chiari Rita, Bamias Aristotelis, Caffo Orazio, Procopio Giuseppe, Bassanelli Maria, Merler Sara, Messina Carlo, Küronya Zsófia, Mosca Alessandra, Bhuva Dipen, Vau Nuno, Incorvaia Lorena, Rebuzzi Sara Elena, Roviello Giandomenico, Zabalza Ignacio Ortego, Rizzo Alessandro, Mollica Veronica, Sorgentoni Giulia, Monteiro Fernando Sabino M., Montironi Rodolfo, Battelli Nicola, Porta Camillo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference29 articles.
1. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. 2. Santoni M, Piva F, Porta C, Bracarda S, Heng DY, Matrana MR, et al. Artificial neural networks as a way to predict future kidney cancer incidence in the United States. Clin Genitourin Cancer. 2021;19(2):e84–91. 3. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. 4. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356(2):115–24. 5. Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J ClinOncol. 2010;28(6):1061–8.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|